Neonatal Screening for Primary Carnitine Deficiency: Lessons Learned from the Faroe Islands
Primary carnitine deficiency is caused by the defective OCTN2 carnitine transporter encoded by the SLC22A5 gene. A lack of carnitine impairs fatty acid oxidation resulting in hypoketotic hypoglycemia, hepatic encephalopathy, skeletal and cardiac myopathy, and arrhythmia. This condition can be detect...
Published in: | International Journal of Neonatal Screening |
---|---|
Main Authors: | , , , , , |
Format: | Text |
Language: | English |
Published: |
Multidisciplinary Digital Publishing Institute
2017
|
Subjects: | |
Online Access: | https://doi.org/10.3390/ijns3010001 |
id |
ftmdpi:oai:mdpi.com:/2409-515X/3/1/1/ |
---|---|
record_format |
openpolar |
spelling |
ftmdpi:oai:mdpi.com:/2409-515X/3/1/1/ 2023-08-20T04:06:22+02:00 Neonatal Screening for Primary Carnitine Deficiency: Lessons Learned from the Faroe Islands Ulrike Steuerwald Allan Lund Jan Rasmussen Nils Janzen David Hougaard Nicola Longo 2017-02-04 application/pdf https://doi.org/10.3390/ijns3010001 EN eng Multidisciplinary Digital Publishing Institute https://dx.doi.org/10.3390/ijns3010001 https://creativecommons.org/licenses/by/4.0/ International Journal of Neonatal Screening; Volume 3; Issue 1; Pages: 1 primary carnitine deficiency carnitine uptake defect newborn screening fatty acid oxidation SLC22A5 OCTN2 mutations maternal carnitine deficiency Faroe Islands Text 2017 ftmdpi https://doi.org/10.3390/ijns3010001 2023-07-31T21:02:35Z Primary carnitine deficiency is caused by the defective OCTN2 carnitine transporter encoded by the SLC22A5 gene. A lack of carnitine impairs fatty acid oxidation resulting in hypoketotic hypoglycemia, hepatic encephalopathy, skeletal and cardiac myopathy, and arrhythmia. This condition can be detected by finding low levels of free carnitine (C0) in neonatal screening. Mothers with primary carnitine deficiency can also be identified by low carnitine levels in their infant by newborn screening. Primary carnitine deficiency is rare (1:40,000–1:140,000 newborns) except in the Faroe Islands (1:300) due to a founder effect. A specific mutation (c.95A>G, p.N32S) is prevalent, but not unique, with three additional mutations (c.131C>T/p.A44V, a splice mutation c.825-52G>A, and a risk-haplotype) recently identified in the Faroese population. In the Faroe Islands, several adult patients suffered sudden death from primary carnitine deficiency leading to the implementation of a nationwide population screening (performed after 2 months of age) in addition to universal neonatal screening. While most affected infants can be identified at birth, some patients with primary carnitine deficiency might be missed by the current neonatal screening and could be better identified with a repeated test performed after 2 months of age. Text Faroe Islands MDPI Open Access Publishing Faroe Islands International Journal of Neonatal Screening 3 1 1 |
institution |
Open Polar |
collection |
MDPI Open Access Publishing |
op_collection_id |
ftmdpi |
language |
English |
topic |
primary carnitine deficiency carnitine uptake defect newborn screening fatty acid oxidation SLC22A5 OCTN2 mutations maternal carnitine deficiency Faroe Islands |
spellingShingle |
primary carnitine deficiency carnitine uptake defect newborn screening fatty acid oxidation SLC22A5 OCTN2 mutations maternal carnitine deficiency Faroe Islands Ulrike Steuerwald Allan Lund Jan Rasmussen Nils Janzen David Hougaard Nicola Longo Neonatal Screening for Primary Carnitine Deficiency: Lessons Learned from the Faroe Islands |
topic_facet |
primary carnitine deficiency carnitine uptake defect newborn screening fatty acid oxidation SLC22A5 OCTN2 mutations maternal carnitine deficiency Faroe Islands |
description |
Primary carnitine deficiency is caused by the defective OCTN2 carnitine transporter encoded by the SLC22A5 gene. A lack of carnitine impairs fatty acid oxidation resulting in hypoketotic hypoglycemia, hepatic encephalopathy, skeletal and cardiac myopathy, and arrhythmia. This condition can be detected by finding low levels of free carnitine (C0) in neonatal screening. Mothers with primary carnitine deficiency can also be identified by low carnitine levels in their infant by newborn screening. Primary carnitine deficiency is rare (1:40,000–1:140,000 newborns) except in the Faroe Islands (1:300) due to a founder effect. A specific mutation (c.95A>G, p.N32S) is prevalent, but not unique, with three additional mutations (c.131C>T/p.A44V, a splice mutation c.825-52G>A, and a risk-haplotype) recently identified in the Faroese population. In the Faroe Islands, several adult patients suffered sudden death from primary carnitine deficiency leading to the implementation of a nationwide population screening (performed after 2 months of age) in addition to universal neonatal screening. While most affected infants can be identified at birth, some patients with primary carnitine deficiency might be missed by the current neonatal screening and could be better identified with a repeated test performed after 2 months of age. |
format |
Text |
author |
Ulrike Steuerwald Allan Lund Jan Rasmussen Nils Janzen David Hougaard Nicola Longo |
author_facet |
Ulrike Steuerwald Allan Lund Jan Rasmussen Nils Janzen David Hougaard Nicola Longo |
author_sort |
Ulrike Steuerwald |
title |
Neonatal Screening for Primary Carnitine Deficiency: Lessons Learned from the Faroe Islands |
title_short |
Neonatal Screening for Primary Carnitine Deficiency: Lessons Learned from the Faroe Islands |
title_full |
Neonatal Screening for Primary Carnitine Deficiency: Lessons Learned from the Faroe Islands |
title_fullStr |
Neonatal Screening for Primary Carnitine Deficiency: Lessons Learned from the Faroe Islands |
title_full_unstemmed |
Neonatal Screening for Primary Carnitine Deficiency: Lessons Learned from the Faroe Islands |
title_sort |
neonatal screening for primary carnitine deficiency: lessons learned from the faroe islands |
publisher |
Multidisciplinary Digital Publishing Institute |
publishDate |
2017 |
url |
https://doi.org/10.3390/ijns3010001 |
geographic |
Faroe Islands |
geographic_facet |
Faroe Islands |
genre |
Faroe Islands |
genre_facet |
Faroe Islands |
op_source |
International Journal of Neonatal Screening; Volume 3; Issue 1; Pages: 1 |
op_relation |
https://dx.doi.org/10.3390/ijns3010001 |
op_rights |
https://creativecommons.org/licenses/by/4.0/ |
op_doi |
https://doi.org/10.3390/ijns3010001 |
container_title |
International Journal of Neonatal Screening |
container_volume |
3 |
container_issue |
1 |
container_start_page |
1 |
_version_ |
1774717399592861696 |